Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 364, ahead of Takeda Pharmaceutical (305) and Waters (194). Figures as of 19 Nov 2026, 16:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International364
- Median
- 30.2
- Combined market value
- SAR 33.49T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 364 | SAR 60.2B | SAR 1,255.89 | 0.47% up | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 305 | SAR 255.9B | SAR 80.08 | 0.38% up | 51% up | ||
| 3 | WatersWAT · Health Care | 194 | SAR 341.7B | SAR 1,738.81 | 0.54% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 135 | SAR 1.24T | SAR 502.56 | 2.76% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 117 | SAR 21.9B | SAR 1,093.96 | 2.37% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 106 | SAR 136B | SAR 920.20 | 2.42% down | 49% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 99.1 | SAR 37.6B | SAR 248.95 | 0.38% up | 117% up | ||
| 8 | BillionToOneBLLN · Health Care | 98.9 | SAR 16.3B | SAR 341.28 | 0.61% down | 4% down | ||
| 9 | SolventumSOLV · Health Care | 96.0 | SAR 54.5B | SAR 320.52 | 1.19% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 92.7 | SAR 174.5B | SAR 149.53 | 5.60% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 85.8 | SAR 186.2B | SAR 141.53 | 3.65% down | 4% down | ||
| 12 | TeleflexTFX · Health Care | 80.8 | SAR 24.4B | SAR 615.54 | 1.06% down | 58% up | ||
| 13 | PenumbraPEN · Health Care | 80.6 | SAR 47.3B | SAR 1,199.72 | 0.24% down | 15% up | ||
| 14 | ICONICLR · Health Care | 78.0 | SAR 54.8B | SAR 731.37 | 0.09% down | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 74.1 | SAR 19B | SAR 50.06 | 3.09% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.8 | SAR 27.9B | SAR 355.41 | 0.32% down | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 71.2 | SAR 57.9B | SAR 902.21 | 2.92% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 68.9 | SAR 64.9B | SAR 581.56 | 1.71% up | 62% up | ||
| 19 | HeartflowHTFL · Health Care | 67.4 | SAR 14.9B | SAR 169.47 | 1.55% down | 66% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | SAR 42.8B | SAR 272.70 | 0.07% down | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.6 | SAR 224.8B | SAR 390.99 | 0.95% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.2 | SAR 88.7B | SAR 434.93 | 1.57% down | 16% up | ||
| 23 | AlconALC · Health Care | 55.2 | SAR 136.4B | SAR 283.84 | 0.54% up | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.7 | SAR 28.1B | SAR 80.53 | 1.87% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 53.2 | SAR 20.5B | SAR 450.76 | 2.19% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.4 | SAR 171.9B | SAR 1,504.68 | 0.61% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 50.3 | SAR 540.5B | SAR 1,559.33 | 1.24% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 49.4 | SAR 27B | SAR 246.57 | 3.03% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.2 | SAR 1.86T | SAR 1,052.12 | 1.93% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.5 | SAR 204B | SAR 2,589.73 | 1.15% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 46.1 | SAR 48.5B | SAR 243.68 | 4.94% down | 109% up | ||
| 32 | West Pharmaceutical ServicesWST · Health Care | 44.9 | SAR 104.4B | SAR 1,499.24 | 1.07% down | 57% up | ||
| 33 | Royalty PharmaRPRX · Health Care | 44.4 | SAR 146.4B | SAR 254.69 | 1.12% down | 79% up | ||
| 34 | GenmabGMAB · Health Care | 44.1 | SAR 119.2B | SAR 193.36 | 1.14% up | 70% up | ||
| 35 | Eli LillyLLY · Health Care | 43.8 | SAR 4.51T | SAR 5,062.39 | 2.40% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 42.3 | SAR 34.6B | SAR 1,166.90 | 1.35% down | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 41.9 | SAR 216.5B | SAR 794.82 | 1.94% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.2 | SAR 46.4B | SAR 55.65 | 0.97% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.2 | SAR 2.39T | SAR 994.52 | 2.77% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.4 | SAR 589.8B | SAR 103.47 | 1.69% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 39.0 | SAR 679.3B | SAR 392.20 | 0.08% up | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.7 | SAR 601.4B | SAR 854.82 | 0.30% down | 3% up | ||
| 43 | Mettler-Toledo InternationalMTD · Health Care | 37.2 | SAR 128B | SAR 6,434.13 | 1.26% down | 24% up | ||
| 44 | HumanaHUM · Health Care | 37.1 | SAR 171.4B | SAR 1,427.34 | 1.36% down | 73% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.7 | SAR 966.6B | SAR 2,608.80 | 0.40% up | 21% up | ||
| 46 | IlluminaILMN · Health Care | 36.4 | SAR 120B | SAR 793.81 | 0.77% up | 76% up | ||
| 47 | Medpace HoldingsMEDP · Health Care | 35.5 | SAR 67B | SAR 2,395.80 | 1.26% down | 10% up | ||
| 48 | Cardinal HealthCAH · Health Care | 35.2 | SAR 235.9B | SAR 1,020.63 | 2.24% down | 34% up | ||
| 49 | Agilent TechnologiesA · Health Care | 35.2 | SAR 188.5B | SAR 668.54 | 0.51% up | 22% up | ||
| 50 | HealthEquityHQY · Health Care | 34.7 | SAR 29.8B | SAR 360.70 | 1.18% down | 3% down | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.6 | SAR 496.8B | SAR 1,959.63 | 2.61% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.5 | SAR 448.8B | SAR 1,178.90 | 1.21% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.5 | SAR 221.3B | SAR 3,519.32 | 0.32% down | 2% up | ||
| 54 | DexComDXCM · Health Care | 31.8 | SAR 112.8B | SAR 302.52 | 2.27% down | 41% up | ||
| 55 | Merit Medical SystemsMMSI · Health Care | 31.6 | SAR 19B | SAR 316.81 | 1.71% down | 1% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 31.0 | SAR 157.5B | SAR 955.64 | 1.19% down | 19% up | ||
| 57 | AvantorAVTR · Health Care | 30.5 | SAR 38.8B | SAR 57.24 | 0.72% down | 40% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.2 | SAR 112.2B | SAR 1,382.17 | 0.62% down | 42% up | ||
| 59 | STERISSTE · Health Care | 30.1 | SAR 92.5B | SAR 952.60 | 2.16% down | 1% up | ||
| 60 | NovartisNVS · Health Care | 28.9 | SAR 1.07T | SAR 567.30 | 2.56% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.0 | SAR 452.7B | SAR 3,920.77 | 3.61% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.8 | SAR 38.4B | SAR 186.14 | 0.13% up | 9% up | ||
| 63 | Protagonist TherapeuticsPTGX · Health Care | 26.7 | SAR 31B | SAR 474.48 | 0.52% down | 51% up | ||
| 64 | LivaNovaLIVN · Health Care | 26.7 | SAR 19.2B | SAR 348.92 | 1.61% down | 77% up | ||
| 65 | Ensign GroupENSG · Health Care | 26.6 | SAR 39.2B | SAR 671.32 | 2.19% down | 2% up | ||
| 66 | ChemedCHE · Health Care | 26.2 | SAR 26.6B | SAR 2,049.40 | 0.07% down | 27% up | ||
| 67 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | SAR 73.1B | SAR 386.37 | 0.30% down | 16% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | 25.8 | SAR 107.1B | SAR 973.16 | 0.10% down | 38% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.7 | SAR 108.2B | SAR 110.67 | 1.02% down | 12% up | ||
| 70 | Lantheus HoldingsLNTH · Health Care | 25.4 | SAR 25B | SAR 382.90 | 0.08% up | 90% up | ||
| 71 | AmgenAMGN · Health Care | 25.3 | SAR 886.5B | SAR 1,638.83 | 1.57% down | 32% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.7 | SAR 1.02T | SAR 654.46 | 2.40% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.6 | SAR 481.2B | SAR 376.23 | 0.42% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.3 | SAR 19.4B | SAR 154.03 | 2.03% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 24.1 | SAR 25.3B | SAR 159.42 | 8.21% down | 77% up | ||
| 76 | Neurocrine BiosciencesNBIX · Health Care | 23.5 | SAR 60.2B | SAR 594.61 | 2.66% down | 17% up | ||
| 77 | Align TechnologyALGN · Health Care | 23.5 | SAR 42.6B | SAR 605.07 | 1.62% down | 23% up | ||
| 78 | Halozyme TherapeuticsHALO · Health Care | 23.1 | SAR 39.5B | SAR 346.70 | 3.52% down | 39% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.1 | SAR 35B | SAR 316.27 | 1.60% down | 20% up | ||
| 80 | Option Care HealthOPCH · Health Care | 22.9 | SAR 17.8B | SAR 118.63 | 0.27% down | 12% up | ||
| 81 | SanofiSNY · Health Care | 22.8 | SAR 413.1B | SAR 172.04 | 2.66% down | 4% down | ||
| 82 | MSA SafetyMSA · Health Care | 22.7 | SAR 25.5B | SAR 662.46 | 0.47% down | 16% up | ||
| 83 | InsuletPODD · Health Care | 22.3 | SAR 35.5B | SAR 512.01 | 2.49% down | 55% down | ||
| 84 | CenteneCNC · Health Care | 22.2 | SAR 119.9B | SAR 242.09 | 4.31% down | 94% up | ||
| 85 | ResMedRMD · Health Care | 21.5 | SAR 124.6B | SAR 886.17 | 2.62% down | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.2 | SAR 89.7B | SAR 2,105.02 | 2.80% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 20.9 | SAR 48.2B | SAR 490.76 | 3.03% down | 20% up | ||
| 88 | Cooper CompaniesCOO · Health Care | 20.6 | SAR 42.7B | SAR 224.53 | 1.47% down | 15% down | ||
| 89 | Regeneron PharmaceuticalsREGN · Health Care | 20.5 | SAR 360.6B | SAR 3,486.10 | 1.71% down | 28% up | ||
| 90 | Smith & NephewSNN · Health Care | 20.4 | SAR 46.9B | SAR 112.27 | 1.29% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.6 | SAR 60B | SAR 246.01 | 3.96% down | 63% up | ||
| 92 | UnitedHealth GroupUNH · Health Care | 18.9 | SAR 1.11T | SAR 1,242.99 | 5.30% down | 12% up | ||
| 93 | CencoraCOR · Health Care | 18.9 | SAR 242.6B | SAR 1,271.33 | 2.69% down | 4% down | ||
| 94 | Boston ScientificBSX · Health Care | 18.2 | SAR 235B | SAR 162.10 | 0.97% down | 55% down | ||
| 95 | Ascendis PharmaASND · Health Care | 17.5 | SAR 65.4B | SAR 996.36 | 1.74% down | 29% up | ||
| 96 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | SAR 139.7B | SAR 308.89 | 1.57% down | 12% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.0 | SAR 34.4B | SAR 259.64 | 1.86% down | 14% down | ||
| 98 | GSKGSK · Health Care | 16.7 | SAR 359.5B | SAR 179.34 | 1.59% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.4 | SAR 313.8B | SAR 1,452.54 | 3.39% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.3 | SAR 360.9B | SAR 1,727.80 | 3.30% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (364), Takeda Pharmaceutical (305) and Waters (194) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 16:07 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SAR 33.49T as of 19 Nov 2026, 16:07 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.